SPCC965.12 Antibody

Shipped with Ice Packs
In Stock

Description

The designation "SPCC965.12" fails to match:

  • UniProtKB/Swiss-Prot entries for fission yeast proteins

  • STRING or KEGG pathway databases

  • Commercial antibody listings from major suppliers (e.g., Sino Biological, Cusabio, MyBioSource)

Potential Explanations for Missing Data

  • Typographical error: Closest matches include SPCC965.09 or SPCC965.14c (see Table 1).

  • Obsolete nomenclature: Possible reclassification in newer genome assemblies.

  • Unpublished research: No preprints or conference abstracts reference this antibody as of March 2025 [1–8].

Recommended Validation Steps

For researchers seeking SPCC965.12:

  1. Sequence verification: Confirm target gene locus using PomBase (pombe genome database).

  2. Epitope mapping: If novel, design immunogens using structural prediction tools (AlphaFold, RoseTTAFold).

  3. Custom antibody development: Protocols for yeast protein antibodies are well-established .

Broader Implications for Antibody Research

Recent advances in monoclonal antibody production (e.g., rapid ASC enrichment , Fc engineering , and broad-spectrum neutralization ) highlight methodologies applicable to hypothetical SPCC965.12 development. Key parameters from analogous systems:

ParameterTypical ValueExample from Literature
Neutralization IC500.1–10 µg/mL (SARS-CoV-2 mAbs) 87G7 mAb: 0.006 µg/mL vs Omicron
Epitope conservation>90% across variants ACE2-binding site hydrophobic patch
Production timeline10 days (ASC to mAb) Expi-HEK-293 transient expression

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC965.12 antibody; Uncharacterized dipeptidase C965.12 antibody; EC 3.4.13.19 antibody
Target Names
SPCC965.12
Uniprot No.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.